ArticleInternational journal of bioprinting2021
Using Plant Proteins to Develop Composite Scaffolds for Cell Culture Applications.
Article in International journal of bioprinting, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Quinoa and Peanut Extracts as Alternatives to Animal-Derived Extracellular Matrix Proteins in Cultured Meat Production.Journal of food science · 2026Article
- Myotube/Adipocyte Powder-Enriched Alginate-Zein Hydrogels Support Myotube Alignment for 3D Myoblast Culture.Foods (Basel, Switzerland) · 2026Article
- Edible Scaffolds for Cultivated Meat Production.Advances in biochemical engineering/biotechnology · 2026Review
- Article
- Mouse Embryonic Fibroblasts-Derived Extracellular Matrix Facilitates Expansion of Inner Ear-Derived Cells.Cell journal · 2023Article
- Machine learning and 3D bioprinting.International journal of bioprinting · 2023Article
- Valorization of agar production residue as a filler in soy protein hydrogels for 3D printing.International journal of bioprinting · 2023Article
- Analyzing Cell-Scaffold Interaction through Unsupervised 3D Nuclei Segmentation.International journal of bioprinting · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrohydrodynamic printing (EHDP) is capable of fabricating scaffolds that consist of micro/nano scale orientated fibers for three-dimensional (3D) cell culture models and drug screening applications. One of the major hurdles that limit the widespread application of EHDP is the lack of diverse biomaterial inks with appropriate printability and desired mechanical and biological properties. In this work, we blended plant proteins with synthetic biopolymer poly(ε-caprolactone) (PCL) to develop composite biomaterial inks, such as PCL/gliadin and PCL/zein for scaffold fabrication through EHDP. The tensile test results showed that the composite materials with a relatively small amount of plant protein portions, such as PCL/gliadin-10 and PCL/zein-10, can significantly improve tensile properties of the fabricated scaffolds such as Young's modulus and yield stress. These scaffolds were further evaluated by culturing mouse embryonic fibroblasts (NIH/3T3) cells and proven to enhance cell adhesion and proliferation, apart from temporary inhibition effects for PCL/gliadin-20 scaffold at the initial growth stage. After these plant protein nanoparticles were gradually released into culture medium, the generated nanoporous structures on the scaffold fiber surfaces became favorable for cellular attachment, migration, and proliferation. As competent candidates that regulate cell behaviors in 3D microenvironment, such composite scaffolds manifest a great potential in drug screening and 3D
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.